Is LDN effective for treating cancer?
Studies have demonstrated LDN’s effectiveness in treating cancer in animals. However, no trials using LDN in human cancers has yet been conducted. Although there have been anecdotal reports of LDN being beneficial for cancer patients, only clinical trials will be able to provide the true answer to this question. LDN’s beneficial effects are achieved through the “rebound effect” it causes (for details please see the explanatory section “How Does Low Dose Naltrexone Work?”,) and the levels of OGF produced during the rebound effect are not necessarily sufficient to slow down or control growth of large tumors. For this reason, OGF is being investigated in clinical trials as a treatment for cancer. For details about OGF, please visit our OGF section.